Literature DB >> 28698140

N-arachidonoyl glycine, another endogenous agonist of GPR55.

Linda Console-Bram1, Sandra M Ciuciu2, Pingwei Zhao3, Robert E Zipkin4, Eugen Brailoiu5, Mary E Abood6.   

Abstract

Interest in lipoamino acids as endogenous modulators of G-protein coupled receptors has escalated due to their involvement in a variety of physiologic processes. In particular, a role for these amino acid conjugates has emerged in the endocannabinoid system. The study presented herein investigated the effects of N-arachidonoyl glycine (NAGly) on a candidate endocannabinoid receptor, GPR55. Our novel findings reveal that NAGly induces concentration dependent increases in calcium mobilization and mitogen-activated protein kinase activities in HAGPR55/CHO cells. These increases were attenuated by the selective GPR55 antagonist ML193 (N-[4-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide), supporting receptor mediated signaling. To our knowledge this is the first report identifying GPR55 as a target of the endogenous lipoamino acid, NAGly.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bafilomycin A1 (PubChem CID 6436223); Calcium; GPR55; Inositol-3-phosphate receptor; ML193, (N-[4-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide) (PubChem CID1261822); Mitogen activated protein kinase; N-arachidonyl glycine; N-arachidonyl glycine (PubChem CID 5283389); Xestopongin C (PubChem CID 9846431); ryanodine (PubChem CID 11317883)

Mesh:

Substances:

Year:  2017        PMID: 28698140      PMCID: PMC5576593          DOI: 10.1016/j.bbrc.2017.07.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release.

Authors:  T Maruyama; T Kanaji; S Nakade; T Kanno; K Mikoshiba
Journal:  J Biochem       Date:  1997-09       Impact factor: 3.387

2.  Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.

Authors:  Linda Console-Bram; Eugen Brailoiu; Gabriela Cristina Brailoiu; Haleli Sharir; Mary E Abood
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

4.  The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.

Authors:  Elena Deliu; Margaret Sperow; Linda Console-Bram; Rhonda L Carter; Douglas G Tilley; Daniel J Kalamarides; Lynn G Kirby; G Cristina Brailoiu; Eugen Brailoiu; Khalid Benamar; Mary E Abood
Journal:  Mol Pharmacol       Date:  2015-05-13       Impact factor: 4.436

Review 5.  Targeted lipidomics: discovery of new fatty acyl amides.

Authors:  Bo Tan; Heather B Bradshaw; Neta Rimmerman; Harini Srinivasan; Y William Yu; Jocelyn F Krey; M Francesca Monn; Jay Shih-Chieh Chen; Sherry Shu-Jung Hu; Sarah R Pickens; J Michael Walker
Journal:  AAPS J       Date:  2006-07-14       Impact factor: 4.009

6.  Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect.

Authors:  Shang-Zhong Xu; Fanning Zeng; Guylain Boulay; Christian Grimm; Christian Harteneck; David J Beech
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 7.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Julia Kargl; Clara Andradas; Andrew J Brown; Andrew Irving; Cristina Sanchez; Maria Waldhoer
Journal:  Mol Endocrinol       Date:  2011-09-29

8.  Identification of endogenous acyl amino acids based on a targeted lipidomics approach.

Authors:  Bo Tan; David K O'Dell; Y William Yu; M Francesca Monn; H Velocity Hughes; Sumner Burstein; J Michael Walker
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

9.  The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Lesley A Ford; Ruth A Ross; Maria Waldhoer; Andrew J Irving
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

10.  GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine.

Authors:  Natasha L Grimsey; Michelle Glass; David B Finlay; Wayne R Joseph
Journal:  PeerJ       Date:  2016-03-21       Impact factor: 2.984

View more
  11 in total

1.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

2.  Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation.

Authors:  Jeremy D Hill; Viviana Zuluaga-Ramirez; Sachin Gajghate; Malika Winfield; Uma Sriram; Slava Rom; Yuri Persidsky
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

3.  Measuring the Content of Endocannabinoid-Like Compounds in Biological Fluids: A Critical Overview of Sample Preparation Methodologies.

Authors:  Heather B Bradshaw; Clare T Johnson
Journal:  Methods Mol Biol       Date:  2023

4.  N-FATTY ACYLGLYCINES: UNDERAPPRECIATED ENDOCANNABINOID-LIKE FATTY ACID AMIDES?

Authors:  Ryan L Anderson; David J Merkler
Journal:  J Biol Nat       Date:  2018-03-03

Review 5.  Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors.

Authors:  Srinagesh Mannekote Thippaiah; Sloka S Iyengar; K Yaragudri Vinod
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

6.  Ablation of PM20D1 reveals N-acyl amino acid control of metabolism and nociception.

Authors:  Jonathan Z Long; Alexander M Roche; Charles A Berdan; Sharon M Louie; Amanda J Roberts; Katrin J Svensson; Florence Y Dou; Leslie A Bateman; Amir I Mina; Zhaoming Deng; Mark P Jedrychowski; Hua Lin; Theodore M Kamenecka; John M Asara; Patrick R Griffin; Alexander S Banks; Daniel K Nomura; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

7.  Broad and Region-Specific Impacts of the Synthetic Cannabinoid CP 55,940 in Adolescent and Adult Female Mouse Brains.

Authors:  Emma Leishman; Michelle N Murphy; Michelle I Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Front Mol Neurosci       Date:  2018-11-27       Impact factor: 5.639

Review 8.  N-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes.

Authors:  Natalia Battista; Monica Bari; Tiziana Bisogno
Journal:  Biomolecules       Date:  2019-12-03

Review 9.  (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders.

Authors:  Jyoti Sihag; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2022-01-14       Impact factor: 3.876

Review 10.  Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?

Authors:  Karen J Thompson; Andrew B Tobin
Journal:  Cell Signal       Date:  2020-01-21       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.